GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » Total Liabilities

Biotika AS (XBRA:1BSL01AE) Total Liabilities : €3.57 Mil (As of Jun. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Biotika AS Total Liabilities?

Biotika AS's Total Liabilities for the quarter that ended in Jun. 2023 was €3.57 Mil.

Biotika AS's quarterly Total Liabilities declined from Jun. 2022 (€3.24 Mil) to Dec. 2022 (€2.90 Mil) but then increased from Dec. 2022 (€2.90 Mil) to Jun. 2023 (€3.57 Mil).

Biotika AS's annual Total Liabilities increased from Dec. 2020 (€3.30 Mil) to Dec. 2021 (€3.72 Mil) but then declined from Dec. 2021 (€3.72 Mil) to Dec. 2022 (€2.90 Mil).


Biotika AS Total Liabilities Historical Data

The historical data trend for Biotika AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS Total Liabilities Chart

Biotika AS Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.69 5.98 3.30 3.72 2.90

Biotika AS Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 3.72 3.24 2.90 3.57

Biotika AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biotika AS's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.052+(0+0.847
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.002)
=2.90

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=28.342-25.442
=2.90

Biotika AS's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.727+(0+0.83
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.009)
=3.57

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=29.941-26.375
=3.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotika AS Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biotika AS's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotika AS (XBRA:1BSL01AE) Business Description

Traded in Other Exchanges
N/A
Address
Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13
Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines